Vegan Omega 3
Natural health product licensed in Canada
- Other names
- Algae Omega 3, Algae Omegas, Algal Omega 3, Algal Omegas, Cardio Omega-3, Omega 3, Omega 3 1000, Schizochytrium Omega 3, Schizochytrium Omegas, Vegan Omegas, Vegeterian Omega 3, Vegeterian Omegas, Veggie Omega 3, Veggie Omegas
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80060979
- Status
- Active licence
- Licence date
- 19 May 2015
- Revision date
- 26 January 2018
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Schizochytrium spp. Source : Schizochytrium spp. - Whole Potency : 0 300-400mg Docosahexaenoic acid | Not specified | Not calculated |
| Schizochytrium spp. Source : Schizochytrium spp. - Whole Potency : 0 150-300mg Eicosapentaenoic acid | Not specified | Not calculated |
| Schizochytrium spp. Source : Schizochytrium spp. - Whole Potency : 0 500-600mg Docosahexaenoic acid/Eicosapentaenoic acid | Not specified | Not calculated |
| Schizochytrium spp. Source : Schizochytrium spp. - Whole Potency : 0 550-700mg Omega-3 Fatty acids | 1,000 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Sodium complexe de cuivre chlorophylline, Carraghénine, Gélatine, Excipient de Tocophérols NF, Amidon de maïs, Sorbitol, Glycérine, Hypromellose, Caramel, Stéaryl fumarate de sodium, Extrait de romarin, NA, Chlorophylle, Huile de tournesol, Palmitate d'ascorbyle, Dioxyde de silicium, Lécithine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 4 Capsule ; maximum: 5 Capsule | 1 Tous les jours |
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps maintain/support cardiovascular health. Helps support cognitive health and/or brain function. Helps to support/maintain normal serum triglyceride/triacylglycerol levels. Helps to support/maintain eye health/function. Helps to support/maintain visual health/function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80060979
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging